Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis and the blood-central nervous system barrier.
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System.
Eculizumab, Neuromyelitis Optica, and Tuberculosis: We Live An Era of Challenging Combinations.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.
[A different approach to the care of patients with MS].
Transcriptional de-repression of ERVWE1 following influenza A virus infection.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis.
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Immunotherapy of Neuromyelitis Optica.
Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
Impact of 24 Weeks of Resistance and Endurance Exercise on Glucose Tolerance in Persons with Multiple Sclerosis.
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Vitamin D supplementation, moderate sun exposure, and control of immune Diseases.
Antenarratives to inform health care research: exploring workplace illness disclosure for people with multiple sclerosis (MS).
Developments in autoimmune channelopathies.
The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Biased Homozygous Haplotypes Across the Human Caveolin 1 Upstream Purine Complex in Parkinson's Disease.
Combination of AIDP and pyramidal signs associated with antecedent hepatitis A infection: a rare (co)occurrence.
[Neurology at the border of centuries: achievements and prospects].
Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis.
Pages
« first
‹ previous
…
386
387
388
389
390
391
392
393
394
…
next ›
last »